Regeneron Pharmaceuticals, Inc.REGNNASDAQ
LOADING
|||
REGNPE Ratio: Discounted Valuation
Trending lower, below historical average, structural decline.
Left:
|||
Price-to-earnings ratio
Latest
17.42
↓ 42% below average
Average (9y)
30.13
Historical baseline
Range
High:98.35
Low:8.27
CAGR
-17.5%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 17.42 | -26.5% |
| 2023 | 23.70 | +33.1% |
| 2022 | 17.81 | +115.5% |
| 2021 | 8.27 | -44.1% |
| 2020 | 14.80 | -23.6% |
| 2019 | 19.38 | +10.5% |
| 2018 | 17.54 | -51.8% |
| 2017 | 36.36 | -23.7% |
| 2016 | 47.65 | -51.5% |
| 2015 | 98.35 | - |